Prostate cancer enhanced mRNA detection assay in whole blood as predictive biomarker of tumor sensitivity to targeted androgen inhibition for men with metastatic castration-resistant prostate cancer (mCRPC)

Authors :: Shibu Thomas
Howard I. Scher
Amrita Herkal
Yashoda Rajpurohit
Erica Simone Dayan
Michael Gormley
Daniel C. Danila
Deborah Ricci
Nicole A. Schreiber
Martin Fleisher
Source :: Journal of Clinical Oncology. 34:5038-5038
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 5038Background: Enzalutamide (ENZ) and abiraterone + prednisone (AA) have transformed the care of pts with mCRPC. Qualified predictive biomarkers are needed to guide treatment selections. Studies o...

Full Text Access

Tools